Home
AI Governance
AI Procurement and Vendor Evaluation

AI Procurement and Vendor Evaluation

Governance starts before purchase. Procurement evaluates intended use, evidence quality, integration burden, monitoring support, model-update practice, and data terms rather than benchmark scores alone.

Most of a clinical AI tool's governance burden is set at procurement. The intended use, the evidence, the integration model, the data terms, and the vendor's approach to updates and monitoring are all easier to negotiate before a contract than after one. A procurement process built for AI treats the purchase as the first governance decision, not a step that precedes governance.

Clinical AI Procurement Checklist

Use this clinical AI procurement scorecard to flag review gaps before a hospital signs a vendor contract, starts a pilot, or expands a clinical AI tool.

July 22, 2026 25 views

How Hospitals Evaluate Clinical AI Vendors

Hospitals should not evaluate clinical AI vendors like ordinary software purchases. The right process starts with a defined clinical problem, then moves through evidence, regulatory status, workflow fit, privacy, governance, contracting, and post-deployment monitoring.

July 22, 2026 20 views

How to Evaluate Clinical AI Readiness

Clinical AI readiness is not just about technical capability. Hospitals need governance, ownership, workflow clarity, data quality, user training, monitoring plans, and enough operational discipline to adopt AI without creating avoidable risk.

July 22, 2026 11 views

About AI Procurement and Vendor Evaluation

What to Evaluate

Intended use and users. The specific clinical task, patient population, and who is expected to act on the output.
Evidence quality. Study design, external validation, prospective data, and whether performance holds across sites and populations, not just headline accuracy.
Regulatory status. Whether the tool is a cleared device, the basis of clearance, and what the labeling permits.
Integration burden. How output reaches the EHR, PACS, or worklist, and what internal work that requires.
Monitoring support. What performance data the vendor provides, in what form, and how often.
Model-update practice. Whether there is a predetermined change control plan and how updates are communicated and validated.
Data terms. PHI handling, training-data use, retention, de-identification, and the business associate agreement.
Total cost. Licensing, integration, infrastructure, and the internal cost of monitoring and governance over the contract term.

Vendor Questions Worth Asking

What is the intended use statement, verbatim, and what is explicitly out of scope?
Where has the tool been externally validated, and can we see the data?
How will it perform on our scanners, coding patterns, or population, and will you support local testing?
What performance metrics will you report to us after go-live, and how often?
How are model updates decided, disclosed, and validated?
What happens to our data, and what are the retention and deletion terms?

How Procurement Connects to Governance

The procurement record should hand off cleanly to the model inventory and the monitoring plan. A vendor that cannot support monitoring or local validation is a governance cost, not just a product limitation.